La chaîne d'options affiche les données clés des options sur actions de Marblegate Acquisition à différents prix d'exercice et dates d'expiration. Les traders utilisent ces informations pour analyser les transactions potentielles et évaluer le sentiment du marché pour Marblegate Acquisition..

Marblegate Acquisition (NASDAQ:GATE) Stock, Chaîne d'Options

Marblegate Acquisition Corp is a blank check company.

Marblegate Acquisition Corp

GATE

Marblegate Acquisition Corp Units (1 Ord Share Class A & 1/2 War)

Marblegate Acquisition Corp Warrants (31/08/2026)

GateToken

GATEKEEPER SYSTEMS INC by Gatekeeper Systems Inc.

Gatekeeper Systems Inc

GATEKEEPER USA INC by Gatekeeper USA, Inc.

Gatekeeper USA Inc

Gates Industrial Corporation plc Ordinary Shares

Gates Industrial Corp PLC

GATEWAY BK FSB OAKLND CA by GATEWAY BK F S B OAKLAND CALIF

Gateway Bank F S B Oakland Calif

Analyst Ratings

Where Blackstone Stands With Analysts

Looking into the current session, McCormick &amp; Co Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MKC#NYSE">MKC</a>) shares are trading at $78.53, after a 2.85% decrease. Over the past month, the stock decreased by 4.94%, but over the past year, it actually increased by 3.84%. With questionable short-term performance like this, and great long-term performance, long-term shareholders might want to start looking into the company's price-to-earnings ratio. 

<img src="https://www.benzinga.com/files/images/story/2025/1743789625_0.png" alt="Past Year Chart" />

<h3>How Does McCormick &amp; Co P/E Compare to Other Companies?</h3>
The P/E ratio is used by long-term shareholders to assess the company's market performance against aggregate market data, historical earnings, and the industry at large. A lower P/E could indicate that shareholders do not expect the stock to perform better in the future or it could mean that the company is undervalued. 
Compared to the aggregate P/E ratio of 23.03 in the Food Products industry, McCormick &amp; Co Inc. has a higher P/E ratio of 27.88. Shareholders might be inclined to think that McCormick &amp; Co Inc. might perform better than its industry group. It's also possible that the stock is overvalued. 

<img src="https://www.benzinga.com/files/images/story/2025/1743789625_1.png" alt="Guage" />

In summary, while the price-to-earnings ratio is a valuable tool for investors to evaluate a company's market performance, it should be used with caution. A low P/E ratio can be an indication of undervaluation, but it can also suggest weak growth prospects or financial instability. Moreover, the P/E ratio is just one of many metrics that investors should consider when making investment decisions, and it should be evaluated alongside other financial ratios, industry trends, and qualitative factors. By taking a comprehensive approach to analyzing a company's financial health, investors can make well-informed decisions that are more likely to lead to successful outcomes.

News

Intraday Update

Markets

Price Over Earnings Overview: McCormick & Co

During the last three months, 14 analysts shared their evaluations of Biogen (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIIB#NASDAQ">BIIB</a>), revealing diverse outlooks from bullish to bearish.
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">5</td>
<td align="right">2</td>
<td align="right">7</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">4</td>
<td align="right">2</td>
<td align="right">5</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts have set 12-month price targets for Biogen, revealing an average target of $190.79, a high estimate of $265.00, and a low estimate of $135.00. A 12.91% drop is evident in the current average compared to the previous average price target of $219.07. 
<img src="https://www.benzinga.com/files/images/story/2025/1743789614_0.png" alt="price target chart" />
<h2>Deciphering Analyst Ratings: An In-Depth Analysis</h2>
In examining recent analyst actions, we gain insights into how financial experts perceive Biogen. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Christopher Raymond</td>
<td>Piper Sandler</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$135.00</td>
<td>$138.00</td>
</tr>
<tr>
<td>George Farmer</td>
<td>Scotiabank</td>
<td>Lowers</td>
<td>Sector Outperform</td>
<td>$224.00</td>
<td>$244.00</td>
</tr>
<tr>
<td>Evan Seigerman</td>
<td>BMO Capital</td>
<td>Lowers</td>
<td>Market Perform</td>
<td>$139.00</td>
<td>$156.00</td>
</tr>
<tr>
<td>Matthew Harrison</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$157.00</td>
<td>$192.00</td>
</tr>
<tr>
<td>Salveen Richter</td>
<td>Goldman Sachs</td>
<td>Lowers</td>
<td>Buy</td>
<td>$245.00</td>
<td>$281.00</td>
</tr>
<tr>
<td>Brian Abrahams</td>
<td>RBC Capital</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$225.00</td>
<td>$231.00</td>
</tr>
<tr>
<td>Geoff Meacham</td>
<td>Citigroup</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$145.00</td>
<td>$160.00</td>
</tr>
<tr>
<td>Mohit Bansal</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$140.00</td>
<td>$165.00</td>
</tr>
<tr>
<td>Andrew Fein</td>
<td>HC Wainwright &amp; Co.</td>
<td>Lowers</td>
<td>Buy</td>
<td>$241.00</td>
<td>$300.00</td>
</tr>
<tr>
<td>Srikripa Devarakonda</td>
<td>Truist Securities</td>
<td>Lowers</td>
<td>Buy</td>
<td>$210.00</td>
<td>$220.00</td>
</tr>
<tr>
<td>Sumant Kulkarni</td>
<td>Canaccord Genuity</td>
<td>Lowers</td>
<td>Buy</td>
<td>$265.00</td>
<td>$298.00</td>
</tr>
<tr>
<td>Geoff Meacham</td>
<td>Citigroup</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$160.00</td>
<td>$190.00</td>
</tr>
<tr>
<td>Mohit Bansal</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$165.00</td>
<td>$190.00</td>
</tr>
<tr>
<td>Srikripa Devarakonda</td>
<td>Truist Securities</td>
<td>Lowers</td>
<td>Buy</td>
<td>$220.00</td>
<td>$302.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Biogen. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Delving into assessments, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings communicate expectations for the relative performance of Biogen compared to the broader market.</li>
<li>Price Targets: Understanding forecasts, analysts offer estimates for Biogen's future value. Examining the current and prior targets provides insight into analysts' changing expectations.</li>
</ul>
Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into Biogen's market standing. Stay informed and make well-considered decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/BIIB/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Biogen analyst ratings.</a>
<h2>About Biogen</h2>
Biogen and Idec merged in 2003, combining forces to market Biogen's multiple sclerosis drug Avonex and Idec's cancer drug Rituxan. Today, Rituxan and next-generation antibody Gazyva (oncology) and Ocrevus (multiple sclerosis) are marketed via a collaboration with Roche. Biogen markets several multiple sclerosis drugs including Plegridy, Tysabri, Tecfidera, and Vumerity. Biogen's newer products include Spinraza (SMA, with partner Ionis), Leqembi (Alzheimers, with partner Eisai), Skyclarys (Friedreich's Ataxia, Reata), Zurzuvae (postpartum depression, Sage), and Qalsody (ALS, Ionis). Biogen has several drug candidates in phase 3 trials in neurology, immunology, and rare diseases.
<h3>Financial Insights: Biogen</h3>
Market Capitalization Analysis: The company exhibits a lower market capitalization profile, positioning itself below industry averages. This suggests a smaller scale relative to peers.
Revenue Growth: Biogen's revenue growth over a period of 3 months has been noteworthy. As of 31 December, 2024, the company achieved a revenue growth rate of approximately 2.87%. This indicates a substantial increase in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Health Care sector.
Net Margin: The company's net margin is below industry benchmarks, signaling potential difficulties in achieving strong profitability. With a net margin of 10.86%, the company may need to address challenges in effective cost control.
Return on Equity (ROE): Biogen's ROE stands out, surpassing industry averages. With an impressive ROE of 1.61%, the company demonstrates effective use of equity capital and strong financial performance.
Return on Assets (ROA): Biogen's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 0.95% ROA, the company effectively utilizes its assets for optimal returns.
Debt Management: Biogen's debt-to-equity ratio is below the industry average. With a ratio of 0.4, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
<h2>What Are Analyst Ratings?</h2>
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BIIB

What 14 Analyst Ratings Have To Say About Biogen

<a href="https://www.washingtonpost.com/world/2025/04/04/britain-trade-deal-trump-tariffs/" title="https://www.washingtonpost.com/world/2025/04/04/britain-trade-deal-trump-tariffs/">https://www.washingtonpost.com/world/2025/04/04/britain-trade-deal-trump-tariffs/</a>

Macro Economic Events

Politics

Global

Economics

General

"Britain, Singed By Trump's Tariffs, Races For U.S. Trade Deal; A Measured Tone Has Set Britain Well Apart From Governments In Europe And Elsewhere Threatening Immediate Countermeasures Against The United States" - Washington Post

President Donald Trump publicly urged the Federal Reserve to cut interest rates, but prediction market data shows that bettors remain skeptical the central bank <a href="https://www.benzinga.com/government/regulations/25/03/44364688/feds-march-meeting-expected-to-signal-no-hurry-on-rate-cuts-as-powell-likely-to-tread-carefully">will act in May</a>.
What Happened: <a href="https://polymarket.com/event/fed-decision-in-may-2025">According </a>to decentralized forecasting platform Polymarket, 72% of market participants believe the Federal Reserve will hold rates steady at its next meeting on May 7, with only 24% pricing in a 25 basis point cut, and a mere 2.7% expecting a deeper 50+ bps reduction.
In a <a href="https://truthsocial.com/@realDonaldTrump">post </a>on Truth Social on Friday, the former president pressed Fed Chair Jerome Powell to act, writing, "This would be a PERFECT time for Fed Chairman Jerome Powell to cut Interest Rates… CUT INTEREST RATES, JEROME, AND STOP PLAYING POLITICS!" Trump cited lower inflation, falling energy prices, and stronger employment as justification for immediate easing.
However, the Fed appears in no rush to move. 
Chair Powell has repeatedly signaled caution, emphasizing the need for "greater clarity" before adjusting monetary policy. 
"It feels like the Fed does not need to be in a hurry," Powell said on Friday, adding that inflationary impacts from Trump's tariff package could further <a href="https://www.benzinga.com/government/regulations/25/04/44648681/powell-cites-tariff-driven-inflation-risks-shrugs-off-trumps-call-for-perfect-time-to-cut-rates">complicate decision-making.</a>
"The tariffs are bigger than almost all forecasters expected," Powell noted, warning they could raise inflation in the coming quarters with "more persistent effects possible."
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/25/04/44645808/bitcoin-has-yet-to-price-in-very-positive-developments-pantera-capitals-dan-morehead-says">Bitcoin Has Yet To Price In &#8216;Very Positive Developments,&#8217; Pantera Capital&#8217;s Dan Morehead Says</a>
Wh It Matters: Bettors seem to be factoring in these mixed signals, balancing political pressure with Powell's message that the Fed still sees two cuts in 2025, but only once the economic outlook becomes more predictable.
Polymarket's trading data shows a sharp drop in the odds of a rate cut since late March, even as Trump's messaging intensifies.
The former president's comments reflect a broader push for looser monetary policy ahead of the election season. But markets are currently pricing in caution, not capitulation. 
Powell said that a year from now, uncertainty should be much lower as impact of Trump policies becomes clearer and that the Fed will wait for greater clarity before further adjustments.
Meanwhile, in a note sent to Benzinga, David Hernandez, Crypto Investment Specialist at 21Shares said Powell's comments follow right after Trump's call for rate cuts, highlighting the growing tension between political pressure and the Fed's cautious approach.
The Fed's caution may come at a cost though, as holding rates too high for too long could cause unnecessary economic stress, which could compound on heightened market volatility.
"With the next FOMC meeting still a month away, the possibility of an emergency rate cut cannot be completely ruled out. Equity markets might need this breather, but from the looks of it, Bitcoin may be a net beneficiary,&#8221; he said.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/04/44644805/bitcoin-is-the-best-of-tech-standard-chartered-says">Bitcoin Is &#8216;The Best Of Tech,&#8217; Standard Chartered Says</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Donald Trump Says 'Cut Interest Rates Jerome', But Polymarket Traders Don't See It Happening In May

Shares of Starwood Property Trust Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STWD#NYSE">STWD</a>) were trading lower on Friday, even as the company&#8217;s affiliate, Starwood Capital Group, <a target="_blank" href="https://www.benzinga.com/pressreleases/25/04/n44645160/starwood-capital-group-acquires-11-master-planned-communities-in-texas-from-hines" rel="noreferrer noopener">announced a real estate transaction</a>.
A joint venture between Starwood Capital and Land Strategies Management (operating as Starwood Land) has completed the acquisition of a portfolio of 11 master-planned communities in Texas from global real estate manager Hines. The deal is valued at approximately $800 million.
The acquired portfolio includes more than 16,000 residential lots and over 600 acres of commercial land across high-growth housing markets: Dallas, Houston, and Austin.
The developments are in advanced stages, with significant infrastructure already completed and active lot sales underway to more than 30 homebuilders.
Also Read: <a target="_blank" href="https://www.benzinga.com/trading-ideas/technicals/25/04/44648530/stock-of-the-day-is-best-buy-about-to-reverse" rel="noreferrer noopener">Stock Of The Day: Is Best Buy About To Reverse?</a>
Communities involved in the transaction include Wildflower Ranch, Creekside, Aster Park, and Furst Ranch in Dallas; Brookewater and Wildrye in Houston; and Mirador in Austin.
&#8220;This is a high-quality portfolio created by a first-class investment manager and developer, and we plan to build upon the excellent work Hines has completed to-date and bring the development vision for these communities to fruition,&#8221; said&nbsp;Mike Moser, CEO of Starwood Land.&nbsp;
Anthony Murphy, Managing Director at Starwood Capital, added that the acquisition aligns with the firm&#8217;s strategy to invest in &#8220;mature,&#8221; well-positioned communities in the nation&#8217;s top housing markets.
According to&nbsp;<a target="_blank" href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw" rel="noreferrer noopener">Benzinga Pro</a>, STWD stock has lost over 6% in the past year. Investors can gain exposure to the stock via iShares Trust iShares Mortgage Real Estate ETF (BATS:<a class="ticker" href="https://www.benzinga.com/stock/REM#BATS">REM</a>).
Price Action: STWD shares are trading lower by 3.91% to $18.45 at last check Friday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/economics/macro-economic-events/25/04/44645681/jpmorgan-raises-recession-risk-to-60-as-largest-us-tax-hike-in-60-years-hits-global-economy" target="_blank" rel="noreferrer noopener">JPMorgan Raises Recession Risk To 60% As &#8216;Largest US Tax Hike&#8217; In 60 Years Hits Global Economy</a></li>
</ul>
Photo via Shutterstock.

Equities

Movers

iShares FTSE NAREIT Mortgage PLUS Capped Index Fund

STWD

What's Going On With Starwood Property Trust Stock On Friday?

BV Financial, Inc. (the "Company") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BVFL#NASDAQ">BVFL</a>), the holding company for BayVanguard Bank (the "Bank"), announced today that the Company has adopted, and received the non-objection of the Federal Reserve Bank of Richmond (the "Federal Reserve") to initiate, a stock repurchase program for up to 10% of the Company's outstanding shares of common stock (approximately 10,594,044 shares). This is the Company's second stock repurchase program since completing its mutual-to-stock conversion and related stock offering on July 31, 2023.

Buybacks

BVFL

BV Financial Announces Second Stock Repurchase Program For Up To 10% Of Outstanding Shares

Shares of Wells Fargo &amp; Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WFC#NYSE">WFC</a>) fell 7% to $61.04 Friday afternoon as President Donald Trump&#8217;s sweeping <a href="https://www.benzinga.com/25/04/44647999/trumps-tariff-war-could-take-us-tech-industry-back-a-decade-while-china-steam-rolls-ahead-analyst-says">reciprocal tariffs</a> sparked a sell-off in financial markets and stoked <a href="https://www.benzinga.com/trading-ideas/25/04/44650039/where-is-the-sp-500-headed-after-trump-tariffs-provoke-dramatic-plunge">growing concerns</a> about a potential global economic slowdown.
As one of the largest U.S. banks, Wells Fargo is significantly exposed to the risks associated with rising trade tensions. Tariffs pose a threat to economic growth, business confidence and consumer activity—all of which are essential to the bank's profitability.
<h3 class="wp-block-heading">What's Behind the Slide?</h3>
Wells Fargo generates a substantial portion of its income from traditional lending, including consumer and commercial loans. A slowdown in economic activity due to tariffs could weigh heavily on loan demand and interest income, particularly if inflation rises <a href="https://www.benzinga.com/economics/macro-economic-events/25/04/44645681/jpmorgan-raises-recession-risk-to-60-as-largest-us-tax-hike-in-60-years-hits-global-economy">while growth stalls</a>.
At the same time, businesses facing uncertainty may scale back expansion plans, leading to weaker demand for commercial credit—a core segment of Wells Fargo's operations.
In addition, the bank's wealth and investment management division, which benefits from stable markets and investor confidence, could come under pressure if volatility continues to rattle sentiment. A sustained market pullback might also affect asset management fees and reduce customer activity.
Read Also: <a href="https://www.benzinga.com/government/regulations/25/04/44648681/powell-cites-tariff-driven-inflation-risks-shrugs-off-trumps-call-for-perfect-time-to-cut-rates">Powell Says It&#8217;s &#8216;Too Soon To Say&#8217; On Rates As Tariffs &#8216;Likely To Raise Inflation&#8217;</a>
Investors can gain exposure to&nbsp;WFC by&nbsp;investing&nbsp;in the Financial Select Sector SPDR Fund (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XLF#NASDAQ">XLF</a>).
<h2 class="wp-block-heading">How To Buy WFC Stock</h2>
By now you're likely curious about how to participate in the market for Wells Fargo &#8211; be it to purchase shares, or even attempt to bet against the company.
Buying shares is typically done through a brokerage account. You can find a list of <a href="https://www.benzinga.com/money/best-stock-trading-platforms">possible trading platforms here.</a> Many will allow you to buy &#8220;fractional shares,&#8221; which allows you to own portions of stock without buying an entire share.
In the case of Wells Fargo, which is trading at $60.65 as of publishing time, $100 would buy you 1.65 shares of stock.
If you're looking to bet against a company, the process is more complex. You'll need access to an options trading platform, or a broker who will allow you to &#8220;go short&#8221; a share of stock by lending you the shares to sell. The process of shorting a <a href="https://www.benzinga.com/money/how-to-short-a-stock">stock can be found at this resource.</a> Otherwise, if your broker allows you to trade options, you can either buy a put option, or sell a call option at a strike price above where shares are currently trading &#8211; either way it allows you to profit off of the share price decline.

What's Going On With Wells Fargo (WFC) Stock?

TD Securities analyst Andrew Charles reiterates Kura Sushi USA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KRUS#NASDAQ">KRUS</a>) with a Hold and maintains $72 price target.

Price Target

Reiteration

KRUS

TD Securities Reiterates Hold on Kura Sushi USA, Maintains $72 Price Target

Trading Ideas

LHSW

Lianhe Sowell International Group Shares Halted On Circuit Breaker To The Downside, Stock Now Down -33.6%

Stifel analyst Jim Duffy reiterates Nike (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NKE#NYSE">NKE</a>) with a Hold and maintains $75 price target.

Stifel Reiterates Hold on Nike, Maintains $75 Price Target

WIIM

ABNB

ALGT

BKNG

EXPE

JBLU

MESA

NCLH

RYAAY

SKYW

Shares of travel and tourism-related companies are trading lower as global markets continue to decline following President Trump's announcement of sweeping tariffs.

Shares of Bank of America Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BAC#NYSE">BAC</a>) plunged 7.5% to $34.42 Friday afternoon as President Donald Trump&#8217;s sweeping reciprocal tariffs sent <a href="https://www.benzinga.com/government/regulations/25/04/44648681/powell-cites-tariff-driven-inflation-risks-shrugs-off-trumps-call-for-perfect-time-to-cut-rates">shockwaves</a> through financial markets, fueling fears of a potential global economic downturn.
As the second-largest U.S. bank by assets, Bank of America finds itself particularly exposed to these <a href="https://www.benzinga.com/general/market-summary/25/04/44643100/us-stocks-likely-to-open-lower-after-the-worst-selloff-since-2020-tariff-announcement-was-100-smoot-hawley-disguised-as-thoughtful-policy-says-expert">escalating trade tensions</a>. Rising tariffs threaten to slow economic growth, dampen corporate lending and curb consumer spending—three critical pillars of the bank's revenue.
What's Driving the Decline: Bank of America, which derives a significant portion of its revenue from interest income on loans and mortgages, now faces heightened concerns that tariffs could trigger inflation while <a href="https://www.benzinga.com/economics/macro-economic-events/25/04/44645681/jpmorgan-raises-recession-risk-to-60-as-largest-us-tax-hike-in-60-years-hits-global-economy">stalling economic activity</a>. 
If businesses pull back on expansion due to trade uncertainty, demand for corporate credit could weaken, impacting the bank's lending operations.
Additionally, Bank of America's investment banking division—which profits from mergers, acquisitions and capital market activities—could take a hit if market volatility persists. 
Heightened uncertainty and global trade disruptions may deter companies from pursuing major deals, further squeezing the bank's fee-based income.
Read Also: <a href="https://www.benzinga.com/economics/macro-economic-events/25/04/44645518/strong-jobs-report-offers-hope-but-will-it-be-enough-to-counter-tariff-turmoil">Strong Jobs Report Offers Hope — But Will It Be Enough To Counter Tariff Turmoil?</a>
<h2 class="wp-block-heading">How To Buy BAC Stock</h2>
Besides going to a brokerage platform to purchase a share &#8211; or fractional share &#8211; of stock, you can also gain access to shares either by buying an exchange traded fund (ETF) that holds the stock itself, or by allocating yourself to a strategy in your 401(k) that would seek to acquire shares in a mutual fund or other instrument. 
For example, in Bank of America&#8217;s case, it is in the Financials sector. An ETF will likely hold shares in many liquid and large companies that help track that sector, allowing an investor to gain exposure to the trends within that segment.
According to data from&nbsp;<a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, BAC has a 52-week high of $48.08 and a 52-week low of $33.67.

What's Going On With Bank Of America (BAC) Shares

HC Wainwright &amp; Co. analyst Yi Chen reiterates Sensus Healthcare (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SRTS#NASDAQ">SRTS</a>) with a Buy and maintains $12 price target.

SRTS

HC Wainwright & Co. Reiterates Buy on Sensus Healthcare, Maintains $12 Price Target

Raymond James analyst Brian MacArthur maintains Wheaton Precious Metals (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WPM#NYSE">WPM</a>) with a Outperform and raises the price target from $75 to $88.

Raymond James Maintains Outperform on Wheaton Precious Metals, Raises Price Target to $88

Shares of Carnival Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CCL#NYSE">CCL</a>) have tumbled 14.5% to $16.33 since Monday&#8217;s open as President Donald Trump&#8217;s new reciprocal tariffs sent shockwaves through global markets, <a href="https://www.benzinga.com/government/regulations/25/04/44647678/nasdaq-100-enters-bear-market-dow-in-correction-territory-traders-await-fed-chair-powells-remarks">stoking concerns</a> of an economic slowdown that could hit the travel industry hard.
Why It Matters: As the world's largest cruise operator, Carnival is particularly vulnerable to economic downturns and rising operational costs—both of which are being amplified by the escalating trade war.
Operating renowned brands like Princess Cruises, Holland America Line and Seabourn, Carnival depends heavily on discretionary consumer spending and international travel.
However, with tariffs <a href="https://www.benzinga.com/markets/25/04/44621408/market-access-has-a-price-trump-unveils-list-of-tariffs-countries-targeted">expected to drive up</a> prices on goods and services, vacation budgets may tighten, leading to weaker cruise bookings. At the same time, higher import costs for fuel, food and ship maintenance could further squeeze profit margins.
Bigger Risks Ahead?: Beyond cost concerns, retaliatory measures from key markets—notably the European Union—pose another significant risk. 
If trade tensions slow global economic growth, consumer confidence could erode, further pressuring demand for leisure travel.
Read Also: <a href="https://www.benzinga.com/government/regulations/25/04/44647678/nasdaq-100-enters-bear-market-dow-in-correction-territory-traders-await-fed-chair-powells-remarks">Nasdaq 100 Enters Bear Market, Dow In Correction Territory, Traders Await Fed Chair Powell&#8217;s Remarks</a>

Carnival Stock Is Down 14% This Week: What's Going On?

Wall Street's sell-off shows no signs of easing into the week's close, in what's shaping up to be the worst week for U.S. <a href="https://www.benzinga.com/markets">equities since March 2020</a>.
The market's bleeding is now visible across the board: the Dow Jones has slipped into correction territory, while the tech-heavy Nasdaq 100 has entered a bear market after falling more than 20% from its highs.
Tech and semiconductor stocks have taken the brunt of the damage, following China's announcement of retaliatory tariffs of 34% on U.S. goods — a tit-for-tat move matching the rate once imposed by President Donald Trump.
The VIX index — also known as the &#8220;market fear gauge&#8221;&nbsp;— spiked 35% to 40 levels, heading for the highest daily close since October 2020.
Other countries are threatening retaliation, fueling fears of a broader global trade war that could disrupt supply chains and weigh heavily on the global economy.
The iShares Semiconductor ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SOXX#NYSE">SOXX</a>) — a key proxy for the U.S. chipmaking industry — has plunged 16% this week, on track for its worst performance since September 2001 at the height of the dot-com crash.
Apple Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) extended its losses by another 4.7% on Friday, heading toward its steepest two-day decline since 2013, as investors brace for potential revenue hits from the new Chinese tariffs.
Even <a href="https://www.benzinga.com/economics/macro-economic-events/25/04/44645518/strong-jobs-report-offers-hope-but-will-it-be-enough-to-counter-tariff-turmoil">a strong U.S. jobs report</a> — with 228,000 payrolls added in March, far above the expected 135,000 — did little to soothe nerves.
Hopes that Fed Chair Jerome Powell might strike a more dovish tone were dashed. He <a href="https://www.benzinga.com/government/regulations/25/04/44648681/powell-cites-tariff-driven-inflation-risks-shrugs-off-trumps-call-for-perfect-time-to-cut-rates">offered no signs of urgency to cut </a>rates, reiterating that the Fed is in no rush, and flagged inflation risks tied to tariffs. Powell stressed the importance of monitoring inflation expectations closely. 
Meanwhile, President Donald Trump continued posting on Truth Social, touting the &#8220;great jobs numbers&#8221; and warning China against behavior it &#8220;cannot afford to do.&#8221; He again pressed Powell to cut rates, saying it's the "perfect time," but his words seem to be losing sway on Wall Street.
As stocks slumped, bonds notched their best day of the year thus far. The popular iShares 20+ Year Treasury Bond ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLT#NASDAQ">TLT</a>) fell 2.1%. Yields on the 10-year Treasury note were down by 10 basis points to 3.94%. 
<h1 class="wp-block-heading">Friday&#8217;s Performance On Major U.S. Indices, ETFs</h1>
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Major Indices</td>
<td>Price</td>
<td>Chg (%)</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>38,924.16</td>
<td>-4.0%</td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>17,616.59</td>
<td>-4.9%</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>5,130.61</td>
<td>-4.9%</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>1,809.22</td>
<td colspan="2">-5.3%</td>
</tr>
</tbody>
</table>
<figcaption class="wp-element-caption">Updated by 12:55 p.m. </figcaption></figure>
According to&nbsp;<a href="https://www.benzinga.com/pro/?utm_source=BZprocontent&amp;t=be2bearmibe3na1">Benzinga Pro</a>&nbsp;data:
<ul>
<li>The&nbsp;SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) sunk 4.6% to $512.41.</li>
<li>The&nbsp;SPDR Dow Jones Industrial Average&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIA#NYSE">DIA</a>) fell 3.9% to $389.56.</li>
<li>The tech-heavy&nbsp;Invesco QQQ Trust Series&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>)&nbsp;plummeted 4.8% to $428.85.</li>
<li>The&nbsp;iShares Russell 2000 ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IWM#NYSE">IWM</a>) nosedived 5.4% to 179.40.</li>
<li>The&nbsp;Energy&nbsp;Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLE#NYSE">XLE</a>) and the Financial Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLF#NYSE">XLF</a>) recorded the heaviest losses, down 7.3% and 6.1%, respectively. </li>
</ul>
<h1 class="wp-block-heading">Friday&#8217;s Biggest Declines Within Large-Cap Stocks</h1>
<ul>
<li>SanDisk Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNDK#NASDAQ">SNDK</a>) plunged 24.66%.</li>
<li>AppLovin Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APP#NASDAQ">APP</a>) fell 18.14%.</li>
<li>New Fortress Energy Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NFE#NASDAQ">NFE</a>) dropped 18.01%.</li>
<li>Civitas Resources, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CIVI#NYSE">CIVI</a>) sank 15.11%.</li>
<li>Weatherford International plc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WFRD#NASDAQ">WFRD</a>) declined 14.76%.</li>
<li>TechnipFMC plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FTI#NYSE">FTI</a>) fell 14.34%.</li>
<li>Ovintiv Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OVV#NYSE">OVV</a>) lost 13.62%. </li>
</ul>
<h1 class="wp-block-heading">Friday&#8217;s Top Gains</h1>
<ul>
<li>Rocket Companies, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RKT#NYSE">RKT</a>) surged 7.57%.</li>
<li>Gap Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GAP#NYSE">GAP</a>) rose 7.00%.</li>
<li>TopBuild Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BLD#NYSE">BLD</a>) jumped 6.49%.</li>
<li>GameStop Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GME#NYSE">GME</a>) climbed 6.08%.</li>
<li>NVR, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NVR#NYSE">NVR</a>) advanced 5.86%.</li>
<li>D.R. Horton, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DHI#NYSE">DHI</a>) gained 6.09%.</li>
</ul>
Read Now: 
<ul>
<li><a href="https://www.benzinga.com/economics/macro-economic-events/25/04/44645681/jpmorgan-raises-recession-risk-to-60-as-largest-us-tax-hike-in-60-years-hits-global-economy">JPMorgan Raises Recession Risk To 60% As &#8216;Largest US Tax Hike&#8217; In 60 Years Hits Global Economy</a></li>
</ul>
Photo: <a href="https://www.shutterstock.com/g/RasyidArt">RasyidArt</a> via Shutterstock

Government

Large Cap

Regulations

Bonds

Broad U.S. Equity ETFs

Treasuries

Econ #s

Tech

ETFs

AAPL

CIVI

SPDR Dow Jones Industrial Average ETF Trust

SNDK

iShares PHLX SOX Semiconductor Sector Index Fund

SOXX

iShares Trust Barclays 20+ Year Treasury Bond Fund

WFRD

Select Sector SPDR-Consumer Discretionary

Wall Street Massacre Rages On, Chipmakers Eye Worst Week Since Dot-Com Burst, Bonds Rally: What's Driving Markets Friday?

Raymond James analyst Brian MacArthur maintains Royal Gold (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RGLD#NASDAQ">RGLD</a>) with a Outperform and raises the price target from $181 to $200.

RGLD

Raymond James Maintains Outperform on Royal Gold, Raises Price Target to $200

Contracts

ORCL

SNAP

President Trump Says Have Made Tremendous Progress On TikTok Deal; I Am Signing An Executive Order To Keep TikTok Up And Running For An Additional 75 Days; Hope To Continue Working In Good Faith With China; We Do Not Want TikTok To "Go Dark."; We Look Forward To Working With TikTok And China To Close The Deal

Alibaba Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BABA#NYSE">BABA</a>) shares are trading lower Friday after China announced a 34% tariff on all goods imported from the U.S.,<a href="https://www.benzinga.com/news/25/04/44645172/china-retaliates-with-34-tariff-on-all-us-imports-urges-trump-to-immediately-cancel-the-tariffs-calls-for-negotiation"> effective April 10. </a>
What To Know: China's finance ministry said <a href="https://www.benzinga.com/markets/equities/25/04/44620423/trumps-sweeping-tariffs-could-cost-us-20-trillion-crash-markets-warn-economists-monstrously-destructive">Trump&#8217;s recent tariffs</a> violate international trade rules and demanded the tariffs be canceled immediately. It called the U.S. measures unilateral and harmful to both countries' economies and global supply chains.
The announcement triggered a selloff in Chinese stocks trading in the U.S., with Alibaba among the hardest hit. The company is sensitive to cross-border tensions due to its international business exposure.
China imposed export restrictions on 16 U.S. companies, revoked export licenses for six others, and added 11 firms to its unreliable entities list, including drone maker Skydio. It also announced tighter controls on rare earth mineral exports.
The escalation follows comments from President Donald Trump, who said tariffs give the U.S. leverage and hinted they could be used in negotiations over TikTok and a BlackRock deal involving Chinese ports. Trump suggested China would respond to pressure to secure approvals on those issues.
Price Action: Alibaba shares were down 11.6% at $114.34 at the time of writing, according to <a href="https://pro.benzinga.com/dashboard?new_user=False&amp;backend=google-oauth2">Benzinga Pro.</a>
<figure class="wp-block-image size-large is-resized"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0404"><img loading="lazy" decoding="async" width="1024" height="531" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/04111832/Screenshot-2025-04-04-at-11.18.09-1024x531.png" alt="" class="wp-image-857789" style="width:453px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/04111832/Screenshot-2025-04-04-at-11.18.09-1024x531.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/04111832/Screenshot-2025-04-04-at-11.18.09-300x156.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/04111832/Screenshot-2025-04-04-at-11.18.09-768x399.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/04111832/Screenshot-2025-04-04-at-11.18.09.png 1534w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/government/regulations/25/04/44647678/nasdaq-100-enters-bear-market-dow-in-correction-territory-as-traders-anxiously-await-powell-remarks">Nasdaq 100 Enters Bear Market, Dow In Correction Territory, Traders Await Fed Chair Powell&#8217;s Remarks</a></li>
</ul>
Image Via Shutterstock.

Comments

Marblegate Acquisition

Marblegate Acquisition (GATE) Options

No option chain data available. Please try again later

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL